ERCC1 and neoplasm: Gandara et al. investigated the association between ERFR mutation and ERCC1 mRNA levels in 1207 NSCLC tumor samples, and reported that tumors harboring activating EGFR mutations were more likely to express low levels of ERCC1 mRNA [17].